statistiche ricercatore

Continente	#
EU - Europa	550
NA - Nord America	475
AS - Asia	247
SA - Sud America	39
AF - Africa	24
OC - Oceania	22
Continente sconosciuto - Info sul continente non disponibili	2
Totale	1.359

Nazione	#
US - Stati Uniti d'America	446
IT - Italia	214
GB - Regno Unito	67
SE - Svezia	61
TW - Taiwan	42
CH - Svizzera	36
DE - Germania	35
HK - Hong Kong	35
IN - India	29
BR - Brasile	28
CA - Canada	26
JP - Giappone	22
TR - Turchia	22
FR - Francia	20
AU - Australia	19
NO - Norvegia	16
IR - Iran	15
NL - Olanda	14
SG - Singapore	14
VN - Vietnam	12
CN - Cina	11
ES - Italia	11
FI - Finlandia	11
DK - Danimarca	9
IE - Irlanda	9
KR - Corea	9
PL - Polonia	8
TH - Thailandia	7
ID - Indonesia	6
ZA - Sudafrica	6
GR - Grecia	5
IL - Israele	5
VE - Venezuela	5
PH - Filippine	4
RU - Federazione Russa	4
BE - Belgio	3
CZ - Repubblica Ceca	3
MU - Mauritius	3
MX - Messico	3
MY - Malesia	3
AE - Emirati Arabi Uniti	2
AR - Argentina	2
AT - Austria	2
BF - Burkina Faso	2
BG - Bulgaria	2
CO - Colombia	2
EU - Europa	2
HR - Croazia	2
MK - Macedonia	2
NG - Nigeria	2
NZ - Nuova Zelanda	2
PT - Portogallo	2
RO - Romania	2
RS - Serbia	2
SA - Arabia Saudita	2
SI - Slovenia	2
SK - Slovacchia (Repubblica Slovacca)	2
TZ - Tanzania	2
ZM - Zambia	2
BW - Botswana	1
CL - Cile	1
CY - Cipro	1
ET - Etiopia	1
GH - Ghana	1
HU - Ungheria	1
IM - Isola di Man	1
IS - Islanda	1
KH - Cambogia	1
KW - Kuwait	1
LB - Libano	1
LV - Lettonia	1
MA - Marocco	1
MT - Malta	1
PK - Pakistan	1
PY - Paraguay	1
QA - Qatar	1
RW - Ruanda	1
SB - Salomone, isole	1
TM - Turkmenistan	1
TN - Tunisia	1
UA - Ucraina	1
UG - Uganda	1
Totale	1.359

Nome	#
Practical implementation of the Kelly criterion: optimal growth rate, number of trades, and rebalancing frequency for equity portfolios, file e2f56ed9-87dc-3eaf-e053-3a05fe0a5d97	1.269
Cost utility analysis of Remdesivir and Dexamethasone treatment for hospitalised COVID-19 patients - a hypothetical study, file e2f56eda-897e-3eaf-e053-3a05fe0a5d97	46
Cost–utility analysis of pharmacogenetic testing based on CYP2C19 or CYP2D6 in major depressive disorder: assessing the drivers of different cost-effectiveness levels from an Italian societal perspective, file b99c264c-8c2b-4e79-a821-3e3e4d864caa	42
Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder, file e2f56ed9-dc07-3eaf-e053-3a05fe0a5d97	5
A scientometric analysis of the effect of COVID-19 on the spread of research outputs, file 46c2b8c9-2a47-4eaa-b640-bb7859e90b91	3
On the Use of Markov Models in Pharmacoeconomics: Pros and Cons and Implications for Policy Makers, file e2f56ed9-79fd-3eaf-e053-3a05fe0a5d97	3
A method to validate clustering partitions, file 44a56990-c27d-4601-9aee-b683c908f753	1
Totale	1.369

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	224	0	0	0	0	4	98	23	17	17	15	18	32
2021/2022	185	32	11	6	7	20	20	17	7	4	4	34	23
2022/2023	362	57	40	12	17	37	25	23	33	23	34	35	26
2023/2024	598	42	105	41	66	57	40	94	91	40	13	9	0
Totale													1.369

UNICA IRIS Institutional Research Information System